Skip to main content

Table 5 Stillbirth rates by ACS administrationa and ACT intervention group and site

From: The global network antenatal corticosteroids trial: impact on stillbirth

 

Argentina

Guatemala

Pakistan

Belgaum

 

Treatment

Control

Treatment

Control

Treatment

Control

Treatment

Control

Characteristic

ACS

No ACS

ACS

No ACS

ACS

No ACS

ACS

No ACS

ACS

No ACS

ACS

No ACS

ACS

No ACS

ACS

No ACS

Deliveries, N

271

1,297

163

1,551

540

5,135

39

3,812

1,871

5,927

125

8,186

1,743

13,228

332

16,407

Stillbirths, N

5

18

3

24

12

94

0

69

117

271

4

347

80

296

4

377

Stillbirths ≥ 20 weeks GA or ≥ 500 g, N (Rate/1000)

5 (18.5)

18 (13.9)

3 (18.4)

24 (15.5)

12 (22.2)

94 (18.3)

0 (0.0)

69 (18.1)

117 (62.5)

271 (45.7)

4 (32.0)

347 (42.4)

80 (45.9)

296 (22.4)

4 (12.0)

377 (23.0)

 

Nagpur

Kenya

Zambia

Total

 

Treatment

Control

Treatment

Control

Treatment

Control

Treatment

Control

Characteristic

ACS

No ACS

ACS

No ACS

ACS

No ACS

ACS

No ACS

ACS

No ACS

ACS

No ACS

ACS

No ACS

ACS

No ACS

Deliveries, N

612

5,822

84

6,351

178

5,708

30

7,007

519

3,043

15

4,550

5,734

40,160

788

47,864

Stillbirths, N

36

110

5

164

16

123

5

148

27

62

2

85

293

974

23

1,214

Stillbirths ≥ 20 weeks GA or ≥ 500 g, N (Rate/1000)

36 (58.8)

110 (18.9)

5 (59.5)

164 (25.8)

16 (89.9)

123 (21.5)

5 (166.7)

148 (21.1)

27 (52.0)

62 (20.4)

2 (133.3)

85 (18.7)

293 (51.1)

974 (24.3)

23 (29.2)

1,214 (25.4)

  1. aData on administration of ACS from the MNH Registry are available for 1,267/1,304 (97.2 %) of stillbirths in the intervention group and 1,237/1,264 (97.9 %) of stillbirths in the control group